122 related articles for article (PubMed ID: 3265880)
1. T cells and myeloid progenitors in patients with severe aplastic anemia (SAA).
Bacigalupo A; Piaggio G; Figari O; Frassoni F; Podesta M; Marmont AM
Blood Cells; 1988; 14(2-3):485-96. PubMed ID: 3265880
[TBL] [Abstract][Full Text] [Related]
2. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
3. Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSF.
Bacigalupo A; Piaggio G; Podestà M; Tong J; Pitto A; Figari O; Benvenuto F; Vassallo F; Tedone E; Grassia L; Van Lint MT; Gualandi F; Hoffman R
Haematologica; 1997; 82(2):133-7. PubMed ID: 9175313
[TBL] [Abstract][Full Text] [Related]
4. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
[TBL] [Abstract][Full Text] [Related]
5. Immune suppression of hematopoiesis in aplastic anemia: activity of T-gamma lymphocytes.
Bacigalupo A; Podestà M; Mingari MC; Moretta L; Van Lint MT; Marmont A
J Immunol; 1980 Oct; 125(4):1449-53. PubMed ID: 6967904
[TBL] [Abstract][Full Text] [Related]
6. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia.
Wodnar-Filipowicz A; Lyman SD; Gratwohl A; Tichelli A; Speck B; Nissen C
Blood; 1996 Dec; 88(12):4493-9. PubMed ID: 8977241
[TBL] [Abstract][Full Text] [Related]
7. Lack of in vitro colony (CFUC) formation and myelosuppressive activity in patients with severe aplastic anemia after autologous hematologic reconstitution.
Bacigalupo A; Podesta' M; Raffo MR; Piaggio G; Van Lint MT; Vimercati R; Spriano VM; Risso M; Marmont AM
Exp Hematol; 1980 Jul; 8(6):795-801. PubMed ID: 7202583
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
Manz CY; Nissen C; Wodnar-Filipowicz A
Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
[TBL] [Abstract][Full Text] [Related]
9. T-derived colony-inhibiting activity (Td/CIA) in aplastic anemia (SAA) and in normal donors.
Bacigalupo A; Podestá M; Frassoni F; Piaggio G; Raffo MR; Repetto M; Van Lint MT; Marmont AM
Prog Clin Biol Res; 1984; 148():173-83. PubMed ID: 6379658
[No Abstract] [Full Text] [Related]
10. Defunct hematopoietic progenitor growth and heterogeneous immunological phenotypes in acquired aplastic anemia of childhood: identification of subsets with decreased hematopoietic progenitors and increased IL15 or IL10 production.
Dirksen U; Asadi-Moghaddam K; Führer M; Burdach S
Klin Padiatr; 1998; 210(4):167-72. PubMed ID: 9743948
[TBL] [Abstract][Full Text] [Related]
11. [Expression of c-kit receptor on the hemopoietic stem/precursor cells of aplastic anemia patients].
Shao Z; Chen G; Zhang H
Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):532-4. PubMed ID: 11721401
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of aplastic anemia.
Nagao T
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):109-15. PubMed ID: 3834649
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies on the pathogenesis of aplastic anemia in Chinese patients.
Da WM
Exp Hematol; 1988 Jun; 16(5):336-9. PubMed ID: 3371427
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune aspects of aplastic anemia.
Baranski BG; Young NS
In Vivo; 1988; 2(1):91-4. PubMed ID: 2979824
[TBL] [Abstract][Full Text] [Related]
15. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
[TBL] [Abstract][Full Text] [Related]
16. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
Bacigalupo A; Valle M; Podestà M; Pitto A; Zocchi E; De Flora A; Pozzi S; Luchetti S; Frassoni F; Van Lint MT; Piaggio G
Exp Hematol; 2005 Jul; 33(7):819-27. PubMed ID: 15963858
[TBL] [Abstract][Full Text] [Related]
17. [Role of Th1 cell in the pathogenesis of aplastic anemia].
He H; Shao Z; He G; Liu H; Shi J; Fu R; Zhao M; Bai J; Jia H; Sun J; Cui Z; Chu Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):574-7. PubMed ID: 12482340
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive therapy in bone marrow aplasia: the stroma functions normally to support hematopoiesis.
Novitzky N; Jacobs P
Exp Hematol; 1995 Dec; 23(14):1472-7. PubMed ID: 8542933
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytes and lymphokines in aplastic anemia: pathogenic role and implications for pathogenesis.
Young NS; Leonard E; Platanias L
Blood Cells; 1987; 13(1-2):87-100. PubMed ID: 3311225
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe aplastic anemia with high-dose methylprednisolone and antilymphocyte globulin.
Marmont AM; Bacigalupo A; Van Lint MT; Frassoni F; Podesta M; Reali G; Piaggio G
Prog Clin Biol Res; 1984; 148():271-87. PubMed ID: 6379665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
